The Clinical Oncology Next Generation Sequencing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Clinical Oncology Next Generation Sequencing Market?
The Clinical Oncology Next Generation Sequencing Global Market Report 2025 illustrates a swift growth in the market size in the past few years. The market expanded from $0.51 billion in 2024 to $0.58 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Clinical Oncology Next Generation Sequencing Industry?
The Clinical Oncology Next Generation Sequencing Global Market Report 2025 predicts that the market will reach $0.95 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.9%.
Download Your Free Sample of the 2025 Clinical Oncology Next Generation Sequencing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Clinical Oncology Next Generation Sequencing Market?
The key drivers in the clinical oncology next generation sequencing market are:
• Rise in instances of cancer
• Advancements and emphasis on precision medicine
• Development and growth in immuno-oncology
• Implementation and wide acceptance of liquid biopsies
Global Market Segmentation: Identifying Major Clinical Oncology Next Generation Sequencing Industry Segments
The clinical oncology next generation sequencing market covered in this report is segmented –
1) By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing
2) By Application: Screening, Companion Diagnostics, Other Diagnostics
3) By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic Laboratories
Pre-order the 2025 Clinical Oncology Next Generation Sequencing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Clinical Oncology Next Generation Sequencing Market?
The key trends in the clinical oncology next generation sequencing market are:
• Comprehensive Genomic Profiling (CGP) is emerging as a significant trend within the clinical oncology next generation sequencing market.
• Immuno-Oncology is also shaping the direction of the field.
• The understanding and study of tumor evolution and heterogeneity is a growing trend.
• The integration of AI and machine learning is being increasingly adopted and is influencing future trends.
Who Are the Top Competitors & Leading Players in the Clinical Oncology Next Generation Sequencing Market?
Major companies in the clinical oncology next generation sequencing market are:
• Thermo Fisher Scientific
• Oxford Nanopore Technologies Ltd.
• QIAGEN N.V.
• Myriad Genetics Inc.
• Illumina Inc.
• F. Hoffmann-La Roche Ltd.
• PerkinElmer Inc.
• Agilent Technologies Inc.
• Pacific Biosciences of California Inc.
• Caris Life Sciences
• Paradigm Diagnostics
• GATC Biotech AG
• Macrogen Inc.
• DNASTAR Inc.
• Exosome Diagnostics Inc.
• Biomatters Ltd.
• Partek Inc.
• Foundation Medicine Inc.
• Becton Dickinson and Company (BD)
• Takara Bio Inc.
• Creative Biolabs
• Mogene LC
• Knome Inc.
• Genomatix Software GmbH
• CLC bio
• GnuBIO Inc.
• Bio-Rad Laboratories Inc.
• BGI Genomics Co. Ltd.
• Guardant Health Inc.
• Invitae Corporation
• Natera Inc.
• NeoGenomics Laboratories Inc.
• Sysmex Corporation
• Veracyte Inc.
• Zymo Research Corporation
• ArcherDX Inc.
• Cepheid
• Karius Inc.
• OncoDNA S.A.
• Personal Genome Diagnostics Inc.
• PierianDx Inc.
Regional Dominance: Which Area Leads the Global Clinical Oncology Next Generation Sequencing Market?
North America was the largest region in the clinical oncology next-generation sequencing market in 2023
